Novasenta

About:

Novasenta develops treatments to transform the lives of patients with cancer.

Website: https://novasenta.com

Top Investors: UPMC Enterprises

Description:

Novasenta develops treatments to transform the lives of patients with cancer. It uses systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. The company aims to identify novel targets to generate effective therapies for various cancers. It was founded in 2018 and is headquartered in Pittsburgh, Pennsylvania.

Total Funding Amount:

$55M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)novasenta.com

Founders:

Dario Vignali, Greg Delgoffe, Robert Ferris

Number of Employees:

11-50

Last Funding Date:

2024-02-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai